Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic avenue for managing metabolic syndromes. These naturally occurring molecules are secreted by the gut in response to meal intake, https://directmysocial.com/story5185399/unveiling-the-therapeutic-potential-of-glp-1-peptides